People · Operator
Named in public records as an officer, director or promoter · active 2013–2013 · Other Health Care
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Alcyone Lifesciences, Inc. | — | Other Health Care | Series B | $93.2M | $151.7M | 2013 |
Edgard Jannotta, Jr. at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Edgard Jannotta, Jr. on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Edgar D. Jannotta, Jr. | 1 | 6 |
| Richard Upton | 1 | 6 |
| Cameron Durrant | 1 | 5 |
| PJ Anand | 1 | 4 |
| David Donabedian | 1 | 4 |
| Stephen D. Oesterle | 1 | 3 |
| Stephen Oesterle | 1 | 3 |
| Edgar D. Jannotta | 1 | 2 |
| Edgar Jannotta, Jr. | 1 | 2 |
| Norbert D. Riedel | 1 | 1 |
| Piratip Pratumsuwan | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.